Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - pollo - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologici per aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - associati a cellule ricombinanti vivi turchia herpesvirus (ceppo hvp360), che esprimono la proteina di fusione di nd virus e la proteina vp2 di ibd virus - aviaria il virus dell'herpes (malattia di marek) + aviaria infettive bursal virus della malattia (malattia di gumboro) + virus della malattia di newcastle/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ricombinante turchia herpesvirus, ceppo vhvt013-69, live - prodotti immunologici per uccelli, pollame, prodotti immunologici - embryonated eggs; chicken - per l'immunizzazione attiva dei polli:per prevenire la mortalità e ridurre i segni clinici e le lesioni infettive bursal malattia. per ridurre la mortalità, i segni clinici e le lesioni della malattia di marek.

Unione Europea - italiano - EMA (European Medicines Agency)

laboratorios hipra, s.a. - vivo attenuato infettive bursal virus della malattia (ibdv), ceppo 1052 - prodotti immunologici per uccelli, pollame, live virali vaccini aviaria infettive bursal virus della malattia (malattia di gumboro) - chicken; embryonated chicken eggs - per l'immunizzazione attiva di 1 giorno-vecchio polli pulcini e embrionate di polli da carne di pollo, uova per ridurre i segni clinici e le lesioni della borsa di fabricius causato da molto virulento aviaria infettive bursal malattia virus infezione.

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologici per aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Unione Europea - italiano - EMA (European Medicines Agency)

sanofi pasteur - chimeric yellow fever dengue virus serotype 1 (live, attenuated), chimeric yellow fever dengue virus serotype 2 (live, attenuated), chimeric yellow fever dengue virus serotype 3 (live, attenuated), chimeric yellow fever dengue virus serotype 4 (live, attenuated) - dengue - vaccini - dengvaxia is indicated for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4 in individuals 6 to 45 years of age with test-confirmed previous dengue infection (see sections 4. 2, 4. 4 e 4. l'uso di dengvaxia dovrebbe essere in conformità con le raccomandazioni ufficiali.

Italia - italiano - Ministero della Salute

boehringer ingelheim vetmedica gmbh - virus vivo ricombinante della malattia di marek associato a cellule sierotipo 1 ceppo rn1250, herpesvirus di tacchino vivo ricombinante (hvt), associato a cellule, che esprime la proteina vp2 del virus della bursite infettiva (ibd), ceppo vhvt 013-69 - virus vivo ricombinante della malattia di marek associato a cellule sierotipo 1 ceppo rn1250 - nd ufp/dose; herpesvirus di tacchino vivo ricombinante (hvt); associato a cellule; che esprime la proteina vp2 del virus della bursite infettiva (ibd); ceppo vhvt 013-69 - nd ufp/dose - avian infectious bursal disease virus (gumboro disease) + avian herpes virus (marek's disease)

Unione Europea - italiano - EMA (European Medicines Agency)

intervet international b.v. - associati a cellule ricombinanti vivi turchia herpesvirus (ceppo hvt/ilt-138), che esprimono le glicoproteine gd e gi infettive laryngotracheitis virus - prodotti immunologici per uccelli, live virali vaccini - pollo - per l'immunizzazione attiva di pulcini di un giorno per ridurre la mortalità, segni clinici e lesioni dovute a infezione da virus della laringotracheite infettiva aviaria (ilt) e virus di marek (md).

Italia - italiano - Ministero della Salute

laboratorios hipra s.a. - avian infectious bursal disease virus, live - avian infectious bursal disease virus; live - 10 u - avian infectious bursal disease virus (gumboro disease)